September was Blood Cancer Awareness Month, a time to recognize and raise awareness for this diverse group of diseases, including acute myeloid leukemia, or AML, which is one of the most common acute leukemias in adults.
While treatments are available for people with AML, like chemotherapy, about half of patients who achieve remission will relapse within one year.
Onureg is the first and only FDA-approved continued AML treatment for adult patients in first remission. The medication, taken in pill form, can help extend remission.
Learn more about blood cancers here.
